Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
2.
Res Dev Disabil ; 63: 151-159, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27133469

ABSTRACT

BACKGROUND AND AIMS: Individuals with mild or borderline intellectual disability (MBID) are at risk of substance use (SU). At present, it is unclear which strategy is the best for assessing SU in individuals with MBID. This study compares three strategies, namely self-report, collateral-report, and biomarker analysis. METHODS AND PROCEDURES: In a sample of 112 participants with MBID from six Dutch facilities providing care to individuals with intellectual disabilities, willingness to participate, SU rates, and agreement between the three strategies were explored. The Substance use and misuse in Intellectual Disability - Questionnaire (SumID-Q; self-report) assesses lifetime use, use in the previous month, and recent use of tobacco, alcohol, cannabis, and stimulants. The Substance use and misuse in Intellectual Disability - Collateral-report questionnaire (SumID-CR; collateral-report) assesses staff members' report of participants' SU over the same reference periods as the SumID-Q. Biomarkers for SU, such as cotinine (metabolite of nicotine), ethanol, tetrahydrocannabinol (THC), and its metabolite THCCOOH, benzoylecgonine (metabolite of cocaine), and amphetamines were assessed in urine, hair, and sweat patches. RESULTS: Willingness to provide biomarker samples was significantly lower compared to willingness to complete the SumID-Q (p<0.001). Most participants reported smoking, drinking alcohol, and using cannabis at least once in their lives, and about a fifth had ever used stimulants. Collateralreported lifetime use was significantly lower. However, self-reported past month and recent SU rates did not differ significantly from the rates from collateral-reports or biomarkers, with the exception of lower alcohol use rates found in biomarker analysis. The agreement between self-report and biomarker analysis was substantial (kappas 0.60-0.89), except for alcohol use (kappa 0.06). Disagreement between SumID-Q and biomarkers concerned mainly over-reporting of the SumID-Q. The agreement between SumID-CR and biomarker analysis was moderate to substantial (kappas 0.48 - 0.88), again with the exception of alcohol (kappa 0.02). CONCLUSIONS AND IMPLICATIONS: In this study, the three strategies that were used to assess SU in individuals with MBID differed significantly in participation rates, but not in SU rates. Several explanations for the better-than-expected performance of self- and collateral-reports are presented. We conclude that for individuals with MBID, self-report combined with collateralreport can be used to assess current SU, and this combination may contribute to collaborative, early intervention efforts to reduce SU and its related harms in this vulnerable group.


Subject(s)
Alcohol Drinking/epidemiology , Intellectual Disability/epidemiology , Marijuana Smoking/epidemiology , Self Report , Smoking/epidemiology , Substance Abuse Detection , Substance-Related Disorders/epidemiology , Adult , Alcohol Drinking/metabolism , Amphetamine-Related Disorders/epidemiology , Amphetamine-Related Disorders/metabolism , Amphetamines/metabolism , Biomarkers , Cocaine/analogs & derivatives , Cocaine/metabolism , Cocaine-Related Disorders/epidemiology , Cocaine-Related Disorders/metabolism , Cotinine/metabolism , Dronabinol/metabolism , Ethanol/metabolism , Female , Hair/chemistry , Humans , Intellectual Disability/psychology , Male , Marijuana Smoking/metabolism , Middle Aged , Netherlands/epidemiology , Severity of Illness Index , Smoking/metabolism , Substance-Related Disorders/diagnosis , Sweat/chemistry , Urine/chemistry , Young Adult
3.
Res Dev Disabil ; 63: 160-166, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27836581

ABSTRACT

BACKGROUND AND AIMS: Adolescents with Intellectual Disability (ID) are at risk for tobacco and alcohol use, yet little or no prevention programs are available for this group. 'Prepared on time' is an e-learning program based on the attitude - social influence - efficacy model originally developed for fifth and sixth grades of mainstream primary schools. The goals of this study were (1) to examine the lifetime use of tobacco and alcohol among this target group and (2) to gain a first impression of the efficacy of 'Prepared on time' among 12-16-year old students with moderate or mild ID (MMID). METHODS AND PROCEDURES: Students form three secondary special-needs schools were assigned to the experimental (e-learning) group (n=37) or the control group (n=36). Pre-intervention and follow-up data (3 weeks after completion) were gathered using semi-structured interviews inquiring about substance use among students with MMID and the behavioral determinants of attitude, subjective norm, modelling, intention, and knowledge. RESULTS: The lifetime tobacco use and alcohol consumption rates in our sample were 25% and 59%, respectively. The e-learning program had a positive effect on the influence of modelling of classmates and friends. No significant effects were found on other behavioral determinants and knowledge. CONCLUSIONS AND IMPLICATIONS: A substantial proportion of adolescents with MMID in secondary special-needs schools use tobacco or alcohol. This study showed that an e-learning prevention program can be feasible for adolescents with MMID.


Subject(s)
Education, Special , Health Knowledge, Attitudes, Practice , Intellectual Disability/psychology , Internet , Smoking Prevention , Substance-Related Disorders/prevention & control , Underage Drinking/prevention & control , Adolescent , Alcohol Drinking/epidemiology , Alcohol Drinking/prevention & control , Child , Female , Humans , Male , Netherlands/epidemiology , Peer Group , Pilot Projects , School Health Services , Schools , Severity of Illness Index , Smoking/epidemiology , Underage Drinking/statistics & numerical data
4.
Res Dev Disabil ; 38: 319-28, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25577182

ABSTRACT

Knowledge regarding substance use (SU) and substance use disorder (SUD) in individuals with mild to borderline intellectual disabilities (ID) has increased over the last decade, but is still limited. Data on prevalence and risk factors are fragmented, and instruments for screening and assessment and effective treatment interventions are scarce. Also, scientific developments in other fields are insufficiently incorporated in the care for individuals with ID and SUD. In this selective and critical review, we provide an overview of the current status of SU(D) in ID and explore insights on the conceptualisation of SUD from other fields such as addiction medicine and general psychiatry. SU(D) turns out to be a chronic, multifaceted brain disease that is intertwined with other physical, psychiatric and social problems. These insights have implications for practices, policies and future research with regard to the prevalence, screening, assessment and treatment of SUD. We will therefore conclude with recommendations for future research and policy and practice, which may provide a step forward in the care for individuals with ID and SUD.


Subject(s)
Intellectual Disability/epidemiology , Substance-Related Disorders/epidemiology , Humans , Mass Screening/methods , Prevalence , Risk Factors , Severity of Illness Index , Substance-Related Disorders/diagnosis , Substance-Related Disorders/rehabilitation
5.
Res Dev Disabil ; 35(4): 808-13, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24530089

ABSTRACT

Persons with mild to borderline intellectual disability (MID) have been identified as a group at risk for substance use disorder (SUD). However, prevalence estimates of co-occurring SUD and MID rely largely on single source studies performed in selected samples. To obtain more reliable population estimates of SUD and MID, this study combines data from an Intellectual Disability Facility (IDF), and an Addiction Treatment Centre (ATC) in a semi-rural area in the Netherlands. Capture-recapture analysis was used to estimate the hidden population (i.e., the population not identified in the original samples). Further analyses were performed for age and gender stratified data. Staff members reported on 88 patients with SUD and MID in the IDF (4.0% of the IDF sample) and 114 in the ATC (5.2% of the ATC sample), with 12 patients in both groups. Only strata for males over 30 years provided reliable population estimates. Based on 97 patients in these strata, the hidden population was estimated at 215. Hence the estimated total population of males over 30 years old with MID and SUD was 312 (95% CI 143-481), approximately 0.16% (0.05-0.25%) of the total population of this age and gender group. This illustrates that while patients with co-occurring SUD and MID often receive professional help from only one service provider, single source data underestimate its prevalence, and thus underestimate treatment and service needs. Therefore, population prevalence estimations of co-occurring SUD and MID should be based on combined multiple source data.


Subject(s)
Intellectual Disability/epidemiology , Substance-Related Disorders/epidemiology , Adult , Data Collection , Female , Humans , Male , Middle Aged , Models, Statistical , Netherlands , Prevalence , Severity of Illness Index , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...